Bioceres Crop Solutions (BIOX) to Release Earnings on Wednesday

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) is scheduled to be posting its 12/31/2023 quarterly earnings results after the market closes on Wednesday, February 7th. Analysts expect Bioceres Crop Solutions to post earnings of $0.07 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last released its quarterly earnings results on Monday, November 13th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.18). Bioceres Crop Solutions had a net margin of 2.71% and a return on equity of 3.40%. The company had revenue of $116.60 million during the quarter, compared to the consensus estimate of $131.53 million. On average, analysts expect Bioceres Crop Solutions to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Bioceres Crop Solutions Price Performance

Shares of BIOX opened at $12.61 on Tuesday. The business has a 50-day moving average of $13.29 and a 200-day moving average of $12.05. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The company has a market capitalization of $791.91 million, a price-to-earnings ratio of 70.06 and a beta of 0.54. Bioceres Crop Solutions has a 1 year low of $9.76 and a 1 year high of $14.20.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of BIOX. Advisor Group Holdings Inc. raised its holdings in shares of Bioceres Crop Solutions by 66.9% during the fourth quarter. Advisor Group Holdings Inc. now owns 2,242 shares of the company’s stock valued at $27,000 after purchasing an additional 899 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Bioceres Crop Solutions by 1.8% in the first quarter. Dimensional Fund Advisors LP now owns 56,453 shares of the company’s stock worth $655,000 after acquiring an additional 1,002 shares in the last quarter. State Street Corp grew its stake in Bioceres Crop Solutions by 2.3% in the first quarter. State Street Corp now owns 72,696 shares of the company’s stock valued at $844,000 after acquiring an additional 1,656 shares during the period. UBS Group AG increased its holdings in shares of Bioceres Crop Solutions by 4.7% during the first quarter. UBS Group AG now owns 37,468 shares of the company’s stock valued at $435,000 after acquiring an additional 1,676 shares in the last quarter. Finally, Stifel Financial Corp lifted its holdings in shares of Bioceres Crop Solutions by 8.3% in the 3rd quarter. Stifel Financial Corp now owns 29,985 shares of the company’s stock worth $339,000 after purchasing an additional 2,303 shares in the last quarter. 13.35% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Roth Mkm dropped their price target on shares of Bioceres Crop Solutions from $31.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, November 1st.

Read Our Latest Stock Analysis on BIOX

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Further Reading

Earnings History for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.